SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
- Status
- TERMINATED
- Phase
- PHASE2
Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2